Chembio Diagnostics, Inc.

NasdaqCM:CEMI Stock Report

Market Cap: US$16.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Chembio Diagnostics Management

Management criteria checks 2/4

Key information

Richard Eberly

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage28.6%
CEO tenure3.1yrs
CEO ownership1.0%
Management average tenure2.2yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

Chembio gets $3.2M contract from CDC to develop rapid test for syphilis

Sep 06

Chembio stock rises 13% amid plans to develop rapid test for monkeypox

Aug 16

Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?

Nov 30
Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?

Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher

Aug 08
Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher

Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?

Jul 22
Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?

Chembio Diagnostics EPS beats by $0.10, beats on revenue

May 06

Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?

Apr 07
Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?

Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?

Jan 16
Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?

Chembio stock gains after COVID-19 tests nab European Union nod

Jan 14

Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?

Dec 12
Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?

Chembio slumps 13% on delay of U.S. nod for coronavirus antibody test

Dec 04

Chembio nabs BARDA contract for rapid respiratory antigen panel test

Dec 02

CEO Compensation Analysis

How has Richard Eberly's remuneration changed compared to Chembio Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022US$2mUS$460k

-US$23m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$36m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$2mUS$477k

-US$34m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$26m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020US$1mUS$315k

-US$26m

Compensation vs Market: Richard's total compensation ($USD1.61M) is above average for companies of similar size in the US market ($USD767.83K).

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.


CEO

Richard Eberly (61 yo)

3.1yrs

Tenure

US$1,610,406

Compensation

Mr. Richard L. Eberly serves as the President and Chief Executive Officer at Chembio Diagnostics, Inc. since March 16, 2020 and has been its Director since May 02, 2020. He joined Chembio in March, 2020. H...


Leadership Team

NamePositionTenureCompensationOwnership
Richard Eberly
President3.1yrsUS$1.61m1.03%
$ 171.6k
Lawrence Steenvoorden
Executive VP1.3yrsUS$1.05m0.15%
$ 24.4k
Javan Esfandiari
Executive VP and Chief Scientific & Technology Officer19.3yrsUS$765.96k0.50%
$ 84.2k
Paul Angelico
Executive VP & COO3yrsno data0.021%
$ 3.6k
Stella Rivera
Vice President of Human Resources1.4yrsno datano data
Charles Caso
Senior Vice President of Global Commercial Operations1.3yrsno data0.021%
$ 3.6k

2.2yrs

Average Tenure

59yo

Average Age

Experienced Management: CEMI's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Richard Eberly
President2.9yrsUS$1.61m1.03%
$ 171.6k
Leslie Teso-Lichtman
Independent Directorless than a yearUS$143.43kno data
John Potthoff
Independent Director4.9yrsUS$100.31k0.15%
$ 24.6k
Katherine Davis
Independent Chairperson15.9yrsUS$123.89k0.31%
$ 52.0k
David William Acheson
Independent Director2.3yrsUS$91.56k0.040%
$ 6.7k
David Bespalko
Independent Director2.1yrsUS$94.06k0.031%
$ 5.2k

2.6yrs

Average Tenure

64yo

Average Age

Experienced Board: CEMI's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.